Original articleA controlled comparison of two fully supervised once-weekly regimens in the treatment of newly diagnosed pulmonary tuberculosis
References (24)
- et al.
Isoniazid uptake and growth inhibition of Mycobacterium tuberculosis in relation to time and concentration of pulsed drug exposures
Tubercle
(1969) - et al.
A four-year follow-up of patients with quiescent pulmonary tuberculosis at the end of a year of chemotherapy with twice-weekly isoniazid plus streptomycin or daily isoniazid plus PAS
Tubercle
(1969) - et al.
Differentitation of Mycobacterium tuberculosis and Mycobacterium bovis by p-nitrobenzoic susceptibility
Tubercle
(1964) Time-concentration relationships of isoniazid with tubercle bacilli in vitro
American Review of Respiratory Diseases
(1960)Further studies on the time-concentration relationships of isoniazid and tubercle bacill in vitro
American Review of Respiratory Diseases
(1965)- et al.
Etude de láction discontinue de 1'isoniazide sur le bacille de Koch par la methode des cultures sur lames
Revue de la Tuberculose et de Pneumologie
(1958) - et al.
Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes
Bulletin of the World Health Organization
(1969) - et al.
A 5-year study of patients with pulmonary tuberculosis in a concurrent comparison of home and sanatorium treatment for one year with isoniazid plus PAS
Bulletin of the World Health Organization
(1966) - et al.
A new method for the determination of N-acetylisoniazid in urine of ambulatory patients
American Review of Respiratory Diseases
(1964) - et al.
Methods of assaying antituberculous drugs in biologic material. 11. The chemical assay of isoniazid
American Review of Respiratory Diseases
(1962)
A 5-year study of patients with pulmonary tuberculosis treated at home in a controlled comparison of isoniazid plus PAS with 3 regimens of isoniazid alone
Bulletin of the World Health Organization
Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis. 3. Serum concentrations of isoniazid produced by three regimens of isoniazid alone and one of isoniazid plus PAS
Bulletin of the World Health Organization
Cited by (0)
- ∗
The Tuberculosis Chemotherapy Centre, Madras-31, India, is under the joint auspices of the Indian Council of Medical Research, the Tamil Nadu Government, and the World Health Organization in collaboration with the Medical Research Council of Great Britain.
The members of the scientific staff of the Centre with major responsibility for the work reported here are: Dr. N. K. Menon, Director; the late Dr. S. Velu, Dr. C. V. Ramakrishnan, Dr. S. Devadatta and Dr. O. Nazareth, Medical Officers; Mrs. M. Jeyalakshmi Monga, Senior Public Health Nurse; Dr. S. P. Tripathy, Dr. P. R. J. Gangadharam and Mrs. S. Subbammal, Bacteriologists; Dr. K. V. Nageswara Rao and Miss K. Prema, Biochemists; Miss S. Joseph, Mr. P. Venkataraman, Mr. S. Kailasam, Miss V. Devaki, Mr. B. N. Gopalan and Miss C. Ross, Laboratory Research Assistants; Mr. A. G. Beer, Technical Officer; Dr. S. Radhakrishna, Mr. P. R. Somasundaram and Mr. N. G. K. Nair, Statisticians; and Mr. B. Janardhanam, Mr. A. S. L. Narayana, Mr. S. Sivasubramanian, Mr. D. Rajappa and Mr. S. Sambamoorthy, Statistical Assistants.
The report was prepared by Dr. S. Radhakrishna in collaboration with Dr. S. P. Tripathy, Dr. S. Devadatta, Mr. P. R. Somasundaram and other scientific staff of the Centre. Dr. Wallace Fox and Prof. D. A. Mitchison gave advice on the preparation of the report as well as the planning of the study.